These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38095685)

  • 1. Application of a deep learning algorithm for three-dimensional T1-weighted gradient-echo imaging of gadoxetic acid-enhanced MRI in patients at a high risk of hepatocellular carcinoma.
    Kim JH; Yoon JH; Kim SW; Park J; Bae SH; Lee JM
    Abdom Radiol (NY); 2024 Mar; 49(3):738-747. PubMed ID: 38095685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing gadoxetic acid-enhanced liver MRI: a synergistic approach with deep learning CAIPIRINHA-VIBE and optimized fat suppression techniques.
    Wei H; Yoon JH; Jeon SK; Choi JW; Lee J; Kim JH; Nickel MD; Song B; Duan T; Lee JM
    Eur Radiol; 2024 Oct; 34(10):6712-6725. PubMed ID: 38492004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Deep Learning-based Super-Resolution and Partial Fourier Reconstruction for Gradient Echo Sequences in Abdominal MRI at 3 Tesla: Shortening Breath-Hold Time and Improving Image Sharpness and Lesion Conspicuity.
    Almansour H; Herrmann J; Gassenmaier S; Lingg A; Nickel MD; Kannengiesser S; Arberet S; Othman AE; Afat S
    Acad Radiol; 2023 May; 30(5):863-872. PubMed ID: 35810067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided hepatocellular carcinoma detection on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging using a convolutional neural network: Feasibility evaluation with multi-sequence data.
    Cho Y; Han YE; Kim MJ; Park BJ; Sim KC; Sung DJ; Han NY; Park YS
    Comput Methods Programs Biomed; 2022 Oct; 225():107032. PubMed ID: 35930863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetic acid-enhanced fat suppressed three-dimensional T1-weighted MRI using a multiecho dixon technique at 3 tesla: emphasis on image quality and hepatocellular carcinoma detection.
    Lee MH; Kim YK; Park MJ; Hwang J; Kim SH; Lee WJ; Choi D
    J Magn Reson Imaging; 2013 Aug; 38(2):401-10. PubMed ID: 23292998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breath-hold High-resolution T1-weighted Gradient Echo Liver MR Imaging with Compressed Sensing Obtained during the Gadoxetic Acid-enhanced Hepatobiliary Phase: Image Quality and Lesion Visibility Compared with a Standard T1-weighted Sequence.
    Ihara K; Onoda H; Tanabe M; Iida E; Ueda T; Kobayashi T; Higashi M; Nickel MD; Imai H; Ito K
    Magn Reson Med Sci; 2024 Apr; 23(2):146-152. PubMed ID: 36740257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-breath-hold thin-slice gadoxetic acid-enhanced hepatobiliary MR imaging using a newly developed three-dimensional fast spoiled gradient-echo sequence.
    Hori M; Kim T; Onishi H; Takei N; Wakayama T; Sakane M; Dia AA; Tsuboyama T; Nakamoto A; Tatsumi M; Tomiyama N
    Magn Reson Imaging; 2016 May; 34(4):545-51. PubMed ID: 26747408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtraction Images From Portal Venous Phase Gadoxetic Acid-Enhanced MRI for Observing Washout and Enhancing Capsule Features in LI-RADS Version 2018.
    Chung JW; Yu JS; Choi JM; Cho ES; Kim JH; Chung JJ
    AJR Am J Roentgenol; 2020 Jan; 214(1):72-80. PubMed ID: 31573851
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017).
    Ding Y; Rao SX; Wang WT; Chen CZ; Li RC; Zeng M
    Cancer Imaging; 2018 Dec; 18(1):48. PubMed ID: 30526674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of gadoxetic acid-enhanced MRI for the differential diagnosis of focal liver lesions: Comparison between estimated intralesional gadoxetic acid retention by T1 mapping and conventional processing methods.
    Morisaka H; Seno D; Sakurai Y; Sano K; Akamine Y; Ichikawa T; Okada Y
    Eur J Radiol; 2021 May; 138():109620. PubMed ID: 33713905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.
    Nakao S; Tanabe M; Okada M; Furukawa M; Iida E; Miyoshi K; Matsunaga N; Ito K
    Jpn J Radiol; 2019 Sep; 37(9):651-659. PubMed ID: 31321619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
    Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
    J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
    Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary phase images of gadoxetic acid-enhanced MRI may improve accuracy of predicting the size of hepatocellular carcinoma at pathology.
    Dong SY; Yang YT; Wang WT; Zhu S; Sun W; Zeng MS; Rao SX
    Acta Radiol; 2022 Jun; 63(6):734-742. PubMed ID: 33969700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Acceleration Three-Dimensional T1-Weighted Dual Echo Dixon Hepatobiliary Phase Imaging Using Compressed Sensing-Sensitivity Encoding: Comparison of Image Quality and Solid Lesion Detectability with the Standard T1-Weighted Sequence.
    Nam JG; Lee JM; Lee SM; Kang HJ; Lee ES; Hur BY; Yoon JH; Kim E; Doneva M
    Korean J Radiol; 2019 Mar; 20(3):438-448. PubMed ID: 30799575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
    Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of free-breathing dynamic T1-weighted sequences in patients at risk of developing motion artifacts undergoing gadoxetic acid-enhanced liver MRI.
    Park SH; Yoon JH; Park JY; Shim YS; Lee SM; Choi SJ; Nickel MD; Lee JM
    Eur Radiol; 2023 Jun; 33(6):4378-4388. PubMed ID: 36512042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.